Clorox (CLX) 1Q16 EPS Beat Driven by Top-Line Growth; UBS Raises Price Target to $105
Tweet Send to a Friend
UBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $105.00 (from $103.00), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
